Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
START: Early Budesonide in Newly Diagnosed Asthma
NCT00641914Phase 4Completed
- Sponsor
- AstraZeneca
- Start
- Oct 1996
- Primary completion
- Feb 2003
- Modality
- Orthosteric Ligands
01
Overview
Phase 4, randomised, double-blind trial in asthma comparing Budesonide with Placebo (2 arms). Primary endpoints: Severe asthma related events at 3 years and Post-bronchodilator FEV1 % of predicted normal at 5 years. Started Oct 1996; status: completed.
02
Drugs
budesonide
03
Conditions
asthma
Beyond the preview
Go deeper on NCT00641914.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00641914.